Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 11/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 4/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23494056 | 0.93 | LMNA (0.50) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL19069168 | 0.90 | TSHR (0.53) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL29619627 | 0.89 | TSHR (0.56) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL18812858 | 0.89 | LMNA (0.47) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL27948433 | 0.88 | TSHR (0.51) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL19240599 | 0.87 | TSHR (0.50) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL39919 | 0.86 | ALDH1A1 (0.59) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL18495622 | 0.85 | TSHR (0.50) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL20344268 | 0.85 | TSHR (0.50) | LMNAHSD17B10TSHRALDH1A1CYP3A4 | |
| SCHEMBL1723850 | 0.84 | ALDH1A1 (0.53) | LMNAHSD17B10TSHRALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681962-B1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2025-05-21 | — | — | EP | claimed |
| US-11643495-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2023-05-09 | — | — | US | claimed |
| US-20220098348-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2022-03-31 | — | — | US | claimed |
| US-12577342-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2026-03-17 | — | — | US | disclosed |
| EP-3681962-B1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2025-05-21 | — | — | EP | disclosed |
| US-20250155808-A1 | RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | ZEON CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| US-20250129195-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2025-04-24 | — | — | US | disclosed |
| US-12187830-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2024070672-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20230357474-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2023-11-09 | — | — | US | disclosed |
| WO-2023189969-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3932906-B1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT | ADEKA CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | ADEKA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| US-11643495-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2023-05-09 | — | — | US | disclosed |
| CN-113544120-B | Novel compound, composition containing same, self-repairing material, surface coating agent, paint, adhesive, battery material, and cured product | 株式会社ADEKA | 2023-05-02 | — | — | CN | disclosed |
| US-20220153698-A1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT | ADEKA CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| US-20220098348-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577342-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | ATM, ACR, ALAD | LMNA 2103/4885HSD17B10 2941/4885TSHR 4014/4885 |
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | H1-0, H1-10, RAD51 | LMNA 2828/4885HSD17B10 2162/4885TSHR 4534/4885 |
| US-20220153698-A1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT | H1-0, H1-10, RAD51 | LMNA 3038/4885HSD17B10 2256/4885TSHR 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.